In Brief: Kessler's last day
Kessler's last day: Outgoing FDA commissioner participates in White House ceremony marking the beginning of FDA tobacco regulations on Feb. 28. David Kessler, MD, is going to Yale Medical School as its dean on July 1 ("The Tan Sheet" Feb. 17, In Brief). At the Feb. 28 session of the Cosmetic, Toiletry & Fragrance Association's annual meeting, President Edward Kavanaugh introduced CTFA outside counsel Peter Barton Hutt (Covington & Burling) by noting speculation that he is a candidate to succeed Kessler. "Rumors around the last week or so have you in the final three candidates," Kavanaugh said. HHS Secretary Donna Shalala reportedly has sent a long list of candidates to the White House...
More from Archive
- • By
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
- • By
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
More from Pink Sheet
- • By
It is unclear in a revised staff manual guide whether Commissioner's National Priority Voucher program approval “recommendations” from the drug and biologic center directors will be advisory or decisional, experts told the Pink Sheet.
- • By
Revised recommendation is based on most recent data on circulating strains in US, where KP.3 is now dominant. Novavax sticks with plans targeting the JN.1 ‘parent strain.’
- • By
Pink Sheet reporter and editors discuss the US FDA’s changes to the COVID-19 vaccine indication and its revocation of the vaccine emergency use authorizations, as well as new vaccine coverage and reimbursement questions.




